SCHEMBL19320571

SCHEMBL19320571

CCCCOC(=O)C(C)(C)CC(CC)c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
TSHR P16473 3/20 0.49
LMNA P02545 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
MAPK1 P28482 2/20 0.49
NR1H2 P55055 1/20 0.49
RNASEL Q05823 1/20 0.49
ESR2 Q92731 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
CHRM2 P08172 3/20 0.39
LTA4H P09960 2/20 0.39
NR5A1 Q13285 1/20 0.39
TDP1 Q9NUW8 3/20 0.38
CHRM1 P11229 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19320564 0.88 SMN1; SMN2 (0.41) ESR1SMN1; SMN2TSHRLMNACYP1A2
SCHEMBL18922371 0.88 ESR1 (0.43) ESR1SMN1; SMN2TSHRLMNACYP1A2
SCHEMBL5961385 0.88 TSHR (0.45) SMN1; SMN2TSHRLMNACYP1A2CYP2D6
SCHEMBL17403428 0.86 ESR1 (0.46) ESR1TSHRLMNACYP1A2CYP2D6
SCHEMBL12554993 0.85 L3MBTL1 (0.40) ESR1SMN1; SMN2TSHRLMNACYP1A2
SCHEMBL17403438 0.83 ELANE (0.47) ESR1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL17403406 0.81 ESR1 (0.47) ESR1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL13041000 0.81 MEN1 (0.42) ESR1SMN1; SMN2TSHRLMNACYP1A2
SCHEMBL2736411 0.80 ESR1 (0.46) ESR1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL16866893 0.79 ESR1 (0.36) ESR1TSHRLMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11796916-B2 Pattern formation methods and photoresist pattern overcoat compositions ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2023-10-24 US disclosed
US-11754927-B2 Photoresist pattern trimming compositions and pattern formation methods ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2023-09-12 US disclosed
US-20180188654-A1 PATTERN-FORMATION METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2018-07-05 US disclosed
US-9869933-B2 Pattern trimming methods ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2018-01-16 US disclosed
US-9760011-B1 Pattern trimming compositions and methods ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2017-09-12 US disclosed
US-20170255103-A1 PATTERN TRIMMING METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2017-09-07 US disclosed
US-20170255102-A1 PATTERN TRIMMING COMPOSITIONS AND METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11754927-B2 Photoresist pattern trimming compositions and pattern formation methods AHR, ALKBH1, CNOT1 ESR1 1142/4885SMN1; SMN2 2356/4885TSHR 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.